Gilligan is the chief operating officer at Amplitude Vascular Systems (AVS), which is developing a new intravascular lithotripsy system for treating severely calcified arterial disease.
He joined the Boston-based startup in March 2023 after a 29-year career at Boston Scientific. He started in 1994 as an engineer in Ireland and moved his way up to VP of program management and R&D, leading the portfolio for a large part of the interventional cardiovascular business.
“I had my fingers on a lot of different areas. I wasn’t in the weeds dealing with too many suppliers — we had a whole supplier engineering group [of] experts who had expert rel…